The BMW M5, once a paragon of performance, has fallen short of expectations with its latest iteration. The plug-in hybrid model, while boasting impressive electric power, has sacrificed weight and acceleration, leaving fans disappointed. The increased weight, now comparable to some Ford F-150s, has hindered its performance despite a powerful twin turbo V8 engine. While the 0-60 mph time of 3.4 seconds is still respectable for a car of its size, it falls short of the 3.1 seconds achieved by its predecessor. Despite these shortcomings, the M5 remains a capable and luxurious business sedan, offering a blend of performance and…
Author: user
The year 1966 was a time of great change and upheaval in America. While the nation was grappling with the Vietnam War, race riots, and anti war protests, it was also witnessing technological advancements like the introduction of the ATM and the miniaturization of televisions. In the sports world, Muhammad Ali was reigning as the World Heavyweight Boxing Champion and the Beatles were taking the music world by storm. Amidst all this, a classic car was born that would go on to become an iconic symbol of American luxury: the 1966 Buick Riviera GS. Iconic 1966 Buick Riviera GS (PC…
By David Shepardson WASHINGTON (Reuters) -A U.S. House committee said on Monday it is investigating the Federal Communications Commission’s decision to deny SpaceX satellite internet unit Starlink $885.5 million in rural broadband subsidies. The FCC said in December reaffirming its position that the decision impacting Elon Musk’s space company was based on Starlink’s failure to meet basic program requirements and that Starlink could not demonstrate it could deliver promised service after SpaceX had challenged the 2022 decision. House Oversight Committee Chair James Comer, a Republican, asked the FCC in a letter Monday to turn over documents by Oct. 21 on…
The Ford Torino, a lesser known sibling of the Mustang, was produced from 1968 to 1976. While it lacks the iconic status of its more famous counterpart, the Torino spawned a few rare and sought-after muscle cars. One of the most notable is the Torino Talladega, built in 1969 to homologate an aerodynamically improved model for NASCAR competition. Powered by the mighty 428-cubic-inch Cobra Jet V8, the Talladega saw limited production with only 756 units built. Its race-spec version, equipped with the 429 cubic inch V8, dominated NASCAR tracks, winning 29 Grand National races and the 1969 championship. Rare Ford Torino…
Jeremie Duchampt, the mastermind behind Jerem Motorcycles, has quickly established himself as a force to be reckoned worldwide of custom bike building. Despite his relatively short tenure, his creations rival those of seasoned professionals. One such masterpiece is the Yamaha XV1000, a stunning blend of streetfighter and cafe racer aesthetics. Starting with a 1983 model, Duchampt stripped the bike down to its bare essentials. The rear subframe was replaced with a custom made looped unit, dramatically altering the bike’s proportions. Jerem Motorcycles’ Custom Yamaha XV1000 (Jonathan Silene) A sleek, two tone saddle and LED lighting strip were added to the…
Columbia Care (OTC:) Inc. (CLMB) stock has reached an unprecedented peak, marking an all-time high of $103.77. This milestone reflects a significant surge in investor confidence and market performance for the company. In contrast, within the same sector, Wayside Technology Group has experienced a remarkable 1-year change, with its stock value soaring by 137.15%. This juxtaposition highlights the dynamic nature of the market, where companies like CLMB are currently enjoying the pinnacle of their stock valuations, while others like Wayside Tech are showcasing impressive year-over-year growth. The achievement of an all-time high for CLMB stock is a testament to the…
Character actors from the Epic Games Fortnite video game dance during the E3 Electronic Entertainment Expo in Los Angeles, on June 12, 2019.Kyle Grillot | Bloomberg | Getty ImagesA U.S. judge issued a permanent injunction on Monday that will force Google to offer alternatives to its Google Play store for downloading apps on Android phones.Google will also be restricted from paying fees or sharing revenue with companies in exchange for them choosing not to compete with Google’s app store. Alphabet stock took a leg lower on the news and was down more than 2% Monday.The ruling from Judge James Donato…
US stocks slipped on Monday afternoon as the 10-year Treasury yield (^TNX) jumped past 4% for the first time since August ahead of a week of key inflation data and the start of earnings season.The Dow Jones Industrial Average (^DJI) fell 1.2%, around 400 points, after notching a fresh record high as stocks soared to close last week. The S&P 500 (^GSPC) shed more than 1%, while the tech-heavy Nasdaq Composite (^IXIC) also dropped more than 1.1%.Stocks sank to session lows with roughly one hour of trading left after a judge ordered Alphabet (GOOG, GOOGL) to open up Google’s app…
In a challenging market environment, Passage Bio Inc (PASG) stock has touched a 52-week low, trading at $0.57. The biotechnology firm, which specializes in genetic medicines for rare, monogenic central nervous system disorders, has faced a tough year, with its stock price reflecting a 1-year change of -3.82%. Investors have shown concern over the company’s pipeline progress and market conditions that have been less than favorable for biotech ventures. The 52-week low represents a significant drop for the company, which is now focusing on strategic initiatives to regain its momentum and investor confidence. In other recent news, Passage Bio, Inc.…
On Monday, CFRA, a financial research firm, upgraded the price target for Pfizer Inc. (NYSE:) shares to $31.00, moving up from the previous target of $30.00. The firm has maintained a “Hold” rating on the stock. The adjustment reflects a valuation set at 10.9 times the projected 2025 earnings per share (EPS), which is still below Pfizer’s historical average price-to-earnings (P/E) ratio. The analyst at CFRA has revised upwards the earnings forecasts for Pfizer, with the 2024 EPS estimate increasing to $2.62 from $2.57 and the 2025 estimate to $2.84 from $2.82. These changes come amidst reports that activist investor…